HANGZHOU TIGERMED CONSULTING CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.75 CNY | +4.47% |
|
+3.49% | +12.33% |
| 25/04 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
| 25/04 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.94B | ||||||
| 46.81B | - | |||||
| 41.29B | ||||||
| 41.37B | ||||||
| 28.87B | ||||||
| 26.06B |
